Reporting owner · CIK 0001739452

Wu Xiaobin

Visual SEC Form 4 history across 2 companies, 19 transactions and 4 filings.

PRESPresident and COOBeOne Medicines Ltd.
Open-market mix
Latest filingAug 27, 2026, 09:12 PM
Filings4Form 4 records
Buying$00 purchases
Selling$26.2M10 sales
Net value−$26.2MBuys minus sells
Companies24 securities
Most recentAug 25, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-55Feb 254Mar 251Aug 26

Net value flow

Buys minus sells

Feb 25
−$12.5M
Mar 25
−$13.6M
Aug 26
−$106.4K

Transaction texture

Ownership and ticket size

Average P/S size$2.6M
Median P/S size$2.4M
Direct18
Indirect1
Aug 25, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern5Derivative Transactionfiling-context4Direct Ownershipfiling-context18Large Holdings Increaseholdings4Large Holdings Reductionholdings9Large Salesize6Repeat Sellerpattern810b5-1 Detectedfiling-context18

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at BeOne Medicines Ltd. on Aug 25, 2026 valued at $106,400.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at BeOne Medicines Ltd. on Aug 25, 2026 valued at $106,400.

Review SEC filing

Associated companies

Visual map of known reporting history

ONCBeOne Medicines Ltd.1 transactions · latest Aug 27, 2026, 09:12 PMBGNEBeiGene, Ltd.18 transactions · latest Mar 08, 2025, 12:24 AM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
ONCWu Xiaobin
PRES
sale10b5-1280-$10.6MS
Direct Ownership 10b5-1 Detected
—08/2708/25
BGNEWu Xiaobin
PRESCOOGC
exercise10b5-1583k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction+1
—03/08/202503/05/2025
BGNEWu Xiaobin
PRESCOOGC
exercise10b5-191.6k$0M
Derivative Transaction Direct Ownership Large Holdings Reduction+1
—03/08/202503/05/2025
BGNEWu Xiaobin
PRESCOOGC
sale10b5-1200-$5.26MS
Cluster Selling Direct Ownership Repeat Seller+1
—03/08/202503/05/2025
BGNEWu Xiaobin
PRESCOOGC
sale10b5-122.5k-$591MS
Cluster Selling Direct Ownership Large Holdings Reduction+3
—03/08/202503/05/2025
BGNEWu Xiaobin
PRESCOOGC
sale10b5-111.3k-$297MS
Cluster Selling Direct Ownership Large Holdings Reduction+3
—03/08/202503/05/2025
BGNEWu Xiaobin
PRESCOOGC
sale10b5-117.8k-$464MS
Cluster Selling Direct Ownership Large Holdings Reduction+3
—03/08/202503/05/2025
BGNEWu Xiaobin
PRESCOOGC
exercise10b5-144.8k$538MM
Direct Ownership Large Holdings Increase 10b5-1 Detected
—03/08/202503/05/2025
BGNEWu Xiaobin
PRESCOOGC
exercise10b5-17.04k$119MM
Direct Ownership Large Holdings Increase 10b5-1 Detected
—03/08/202503/05/2025
BGNEWu Xiaobin
PRESCOOGC
grant10b5-1103k$0A
Direct Ownership 10b5-1 Detected
—03/08/202503/05/2025

Wu Xiaobin Insider Activity FAQ

SEC Form 4 context

Who is Wu Xiaobin?

Wu Xiaobin is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001739452.

Which companies has Wu Xiaobin reported transactions for?

BeOne Medicines Ltd., BeiGene, Ltd.

When was Wu Xiaobin's latest insider buy?

No open-market insider purchase is available for this period.

When was Wu Xiaobin's latest insider sale?

sale at BeOne Medicines Ltd. on Aug 25, 2026 valued at $106,400.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.